hasTargetDisease
P20980
predicate
Indicates that an entity (such as a treatment, study, or intervention) is directed toward, intended to affect, or primarily concerned with a specified disease.
Aliases (6)
- hasTherapeuticArea ×7
- therapeuticArea ×5
- targetDisease ×4
- targetsDisease ×3
- diseaseArea ×1
- hasFDAIndicationText ×1
Sample triples (22)
| Subject | Object |
|---|---|
| Action and Investment to defeat Malaria | vector-borne diseases ("diseaseArea") → |
| Advance Market Commitment for pneumococcal vaccines | pneumococcal disease → |
| Diabetes Group | endocrinology ("therapeuticArea") → |
| Diabetes Group | metabolic diseases ("therapeuticArea") → |
| Eisai | central nervous system disorders ("hasTherapeuticArea") → |
| Eisai | epilepsy ("hasTherapeuticArea") → |
| Eisai | hematologic malignancies ("hasTherapeuticArea") → |
| Eisai | solid tumors ("hasTherapeuticArea") → |
| Fampyra | neurology ("therapeuticArea") → |
| Guinea Worm Eradication Program | Guinea worm disease ("targetDisease") → |
| Guinea Worm Eradication Program | dracunculiasis ("targetDisease") → |
| Janssen COVID-19 Vaccine | COVID-19 ("targetDisease") → |
| Leqembi | treatment of Alzheimer’s disease ("hasFDAIndicationText") → |
| Lucentis | ophthalmology ("hasTherapeuticArea") → |
| River Blindness Program | onchocerciasis ("targetsDisease") → |
| River Blindness Program | river blindness ("targetsDisease") → |
| Spinraza | neurology ("hasTherapeuticArea") → |
| Spinraza | rare diseases ("hasTherapeuticArea") → |
| Tecentriq | immuno-oncology ("therapeuticArea") → |
| Tecentriq | oncology ("therapeuticArea") → |
| Trachoma Control Program | trachoma ("targetsDisease") → |
| rVSV-ZEBOV | Ebola virus disease ("targetDisease") → |